keyword
https://read.qxmd.com/read/38227433/complement-c4d-as-a-biomarker-for-systemic-lupus-erythematosus-and-lupus-nephritis
#21
REVIEW
Sihao Qin, Xueyao Wang, Jiahui Wang, Hao Wu
Background: Increasing studies in the last decade have led to the widespread understanding that C4d, a split product of complement component 4 (C4), is a potential biomarker for systemic lupus erythematosus (SLE) and lupus nephritis (LN). Purpose : The aim of this review is to summarize the highlights of studies investigating the use of C4d as a biomarker for diagnosing and monitoring SLE and LN patients. Data collection: we searched PubMed/Medline and Wanfang databases using the terms "C4d and systemic lupus erythematosus", "C4d and lupus nephritis", and "Complement C4d"...
February 2024: Lupus
https://read.qxmd.com/read/38178632/association-between-urinary-c4d-levels-and-disease-progression-in-iga-nephropathy
#22
JOURNAL ARTICLE
Yaping Dong, Zi Wang, Weiyi Guo, Li Zhu, Xujie Zhou, Sufang Shi, Lijun Liu, Jicheng Lv, Hong Zhang
BACKGROUND: C4d mesangial deposition, a hallmark of lectin pathway activation in IgA nephropathy (IgAN), has been shown to be associated with risk of kidney failure. To date, the relationship between urinary C4d and renal outcome remain unelucidated. METHODS: A total of 508 patients with biopsy-proven IgAN were enrolled in this study, whose baseline urine samples at the time of biopsy were collected and the levels of urinary C4d were quantified by enzyme-linked immunosorbent assay...
January 4, 2024: Nephrology, Dialysis, Transplantation
https://read.qxmd.com/read/38171993/-pre-histologic-antibody-mediated-rejection-detected-by-donor-derived-cell-free-dna-and-a-novel-tissue-gene-expression-assay-a-case-report
#23
JOURNAL ARTICLE
Tara Ruder, Nikhil A Reddy, Hao Zhang, Xin J Zhou, Anna Curtis, Machaiah M Madhrira, Ashraf I Reyad, Grigoriy Shekhtman, Sridhar R Allam
BACKGROUND: Despite its well-characterized association with poor long-term graft outcomes, subclinical antibody-mediated rejection (ABMR) in recipients of kidney transplants continues to pose a significant diagnostic and therapeutic challenge. Specifically, its detection currently relies on invasive histologic surveillance, a relatively uncommon practice among US transplant centers. We describe a subclinical, "pre-histologic" antibody-mediated rejection identified and characterized by a combination of novel molecular tools, donor-derived cell-free DNA (dd-cfDNA), and molecular histology...
January 2, 2024: Transplantation Proceedings
https://read.qxmd.com/read/38150328/neutrophil-depletion-attenuates-antibody-mediated-rejection-in-a-renal-transplantation-mouse-model
#24
JOURNAL ARTICLE
Xingku Li, Yakun Zhao, Wenying Sun, Cong Zhang, Yadi Yu, Bo Du, AiShun Jin, Ye Liu
Antibody-mediated rejection (AMR) can cause graft failure following renal transplantation. Neutrophils play a key role in AMR progression, but the exact mechanism remains unclear. We investigated the effect of neutrophils on AMR in a mouse kidney transplantation model. The mice were divided into five groups: syngeneic transplantation (Syn), allograft transplantation (Allo), and three differently treated AMR groups. The AMR mouse model was established using skin grafts to pre-sensitize recipient mice. Based on the AMR model, Ly6G-specific monoclonal antibodies were administered to deplete neutrophils (NEUT-/- + AMR) and TACI-Fc was used to block B-cell-activating factor (BAFF)/a proliferation-inducing ligand (APRIL) signaling (TACI-Fc + AMR)...
December 27, 2023: Clinical and Experimental Immunology
https://read.qxmd.com/read/38135573/corrigendum-to-microvascular-inflammation-in-the-absence-of-human-leukocyte-antigen-donor-specific-antibody-and-c4d-an-orphan-category-in-banff-classification-with-cytotoxic-t-and-natural-killer-cell-infiltration-american-journal-of-transplantation-23-2023
#25
Anna Buxeda, Laura Llinàs-Mallol, Javier Gimeno, Dolores Redondo-Pachón, Carlos Arias-Cabrales, Carla Burballa, Adrián Puche, Miguel López-Botet, José Yélamos, Carlos Vilches, Maarten Naesens, María José Pérez-Sáez, Julio Pascual, Marta Crespo
No abstract text is available yet for this article.
December 11, 2023: American Journal of Transplantation
https://read.qxmd.com/read/38128610/multiomic-profiling-of-transplant-glomerulopathy-reveals-a-novel-t-cell-dominant-subclass
#26
JOURNAL ARTICLE
Iacopo Cristoferi, Hilal Varol, Myrthe van Baardwijk, Layla Rahiem, Karishma A Lila, Thierry P P van den Bosch, Carla C Baan, Dennis A Hesselink, Rafael Kramann, Robert C Minnee, Dana A M Mustafa, Marlies E J Reinders, Dave L Roelen, Shazia P Shahzad-Arshad, Rex N Smith, Andrew P Stubbs, Robert B Colvin, Ivy A Rosales, Marian C Clahsen-van Groningen
Kidney transplant (KTx) biopsies showing transplant glomerulopathy (TG) (glomerular basement membrane double contours (cg) > 0)) and microvascular inflammation (MVI) in the absence of C4d staining and donor-specific antibodies (DSA)s do not fulfill the criteria for chronic active antibody-mediated rejection (CA-AMR) diagnosis and do not fit into any other Banff category. To investigate this, we initiated a multicenter intercontinental study encompassing 36 cases, comparing the immunomic and transcriptomic profiles of 14 KTx biopsies classified as cg+MVI DSA- /C4d- with 22 classified as CA-AMR DSA+ /C4d+ through novel transcriptomic analysis using the NanoString Banff-Human Organ Transplant (B-HOT) panel and subsequent orthogonal subset analysis using two innovative 5-marker multiplex immunofluorescent panels...
December 19, 2023: Kidney International
https://read.qxmd.com/read/38106112/antibody-mediated-rejection-is-not-associated-with-worse-survival-in-adherent-heart-transplant-patients-in-the-contemporary-era
#27
Paul J Kim, Vincenzo Cusi, Ashley Cardenas, Yuko Tada, Florin Vaida, Nicholas Wettersten, Jennifer Chak, Priyesha Bijlani, Victor Pretorius, Marcus Anthony Urey, Gerald P Morris, Grace Lin
BACKGROUND: C4d immunostaining of surveillance endomyocardial biopsies (EMB) and testing for donor specific antibodies (DSA) are routinely performed in the first year of heart transplantation (HTx) in adult patients. C4d and DSA positivity have not been evaluated together with respect to clinical outcomes in the contemporary era (2010-current). METHODS: This was a single center, retrospective study of consecutive EMBs performed between November 2010 and April 2023...
December 8, 2023: medRxiv
https://read.qxmd.com/read/38099111/immunohistochemical-evaluation-of-c4d-and-c3d-markers-in-bullous-pemphigoid-as-a-substitute-for-direct-immunofluorescence-technique
#28
JOURNAL ARTICLE
Mahsa Akbari Oryani, Naser Tayebi-Meybodi, Yalda Nahidi, Mohsen Soltani Sabi, Monavar Afzal Aghaei
BACKGROUND: There are several methods for the diagnosis of autoimmune bullous disease. Direct immunofluorescent (DIF) testing is an important diagnostic method in the diagnosis of immunobullous disease but requires skilled pathologist, fresh tissue and well-equipped laboratory to perform the procedure. The immunohistochemistry analysis of C4d and C3d is easily compared with other methods. This study was conducted to assess the value of immunohistochemistry (IHC) analysis for expressions of C3d and C4d in the diagnosis of bullous pemphigoid (BP)...
2023: Indian Journal of Dermatology
https://read.qxmd.com/read/38070662/blockade-of-blys-inhibits-b-cell-responses-and-antibody-production-for-the-prevention-of-chronic-transplant-rejection
#29
JOURNAL ARTICLE
Tao Liao, Xiaoyi Shi, Fei Han, Yuchen Wang, Wenli Zeng, Rumin Liu, Ziyan Yan, Renfei Xia, Zhengyu Huang, Jian Xu, Yun Miao
BACKGROUND: Chronic rejection, closely related to the activation of B cells and donor-specific antibody (DSA) production, has unsatisfactory therapeutic outcomes. B lymphocyte stimulator (BLyS) is a major regulatory factor that controls the activation and differentiation of B cells. However, it remains unclear whether BLyS blockade can regulate B and plasma cells in the transplantation setting and affect chronic rejection. Here, we investigated the efficacy of the BLyS inhibitors belimumab and telitacicept in controlling B-cell response and preventing chronic rejection...
December 7, 2023: Journal of Heart and Lung Transplantation
https://read.qxmd.com/read/38055614/discovery-and-characterization-of-cross-reactive-intrahepatic-antibodies-in-severe-alcoholic-hepatitis
#30
JOURNAL ARTICLE
Ali Reza Ahmadi, Guang Song, Tianshun Gao, Jing Ma, Xiaomei Han, Ming-Wen Hu, Andrew M Cameron, Russell N Wesson, Benjamin Philosophe, Shane Ottmann, Elizabeth King, Ahmet Gurakar, Le Qi, Brandon Peiffer, James Burdick, Robert Anders, Zhanxiang Zhou, Hongkun Lu, Dechun Feng, Chien-Sheng Chen, Jiang Qian, Bin Gao, Heng Zhu, Zhaoli Sun
The pathogenesis of antibodies in severe alcoholic hepatitis (SAH) remains unknown. We analyzed immunoglobulins (Ig) in explanted livers from SAH patients (n=45) undergoing liver transplantation and tissues from corresponding healthy donors (HD, n=10) and found massive deposition of IgG and IgA isotype antibodies associated with complement fragment C3d and C4d staining in ballooned hepatocytes in SAH livers. Ig extracted from SAH livers, but not patient serum exhibited hepatocyte killing efficacy. Employing human and Escherichia coli K12 proteome arrays, we profiled the antibodies extracted from explanted SAH, livers with other diseases, and HD livers...
December 6, 2023: ELife
https://read.qxmd.com/read/38053977/targeting-complement-in-iga-nephropathy
#31
REVIEW
Fernando Caravaca-Fontán, Eduardo Gutiérrez, Ángel M Sevillano, Manuel Praga
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. Recent years have witnessed significant improvements in the understanding of the pathogenesis of IgAN and particularly, the pathogenic role of complement activation. The alternative complement pathway is the major complement cascade activator in IgAN, and glomerular C3 deposition has been shown to correlate with disease progression. In addition, several studies have provided insight into the pathogenic role of factor H-related proteins -1 and -5 in IgAN, as independent players in complement dysregulation...
December 2023: Clinical Kidney Journal
https://read.qxmd.com/read/38032300/the-banff-2022-kidney-meeting-report-reappraisal-of-microvascular-inflammation-and-the-role-of-biopsy-based-transcript-diagnostics
#32
JOURNAL ARTICLE
Maarten Naesens, Candice Roufosse, Mark Haas, Carmen Lefaucheur, Roslyn B Mannon, Benjamin A Adam, Olivier Aubert, Georg A Böhmig, Jasper Callemeyn, Marian Clahsen-van Groningen, Lynn D Cornell, Anthony J Demetris, Cinthia B Drachenberg, Gunilla Einecke, Agnes B Fogo, Ian W Gibson, Philip Halloran, Luis G Hidalgo, Catherine Horsfield, Edmund Huang, Željko Kikić, Nicolas Kozakowski, Brian Nankivell, Marion Rabant, Parmjeet Randhawa, Leonardo V Riella, Ruth Sapir-Pichhadze, Carrie Schinstock, Kim Solez, Anat R Tambur, Olivier Thaunat, Chris Wiebe, Dina Zielinski, Robert Colvin, Alexandre Loupy, Michael Mengel
The XVI-th Banff Meeting for Allograft Pathology was held at Banff, Alberta, Canada, from 19th to 23rd September 2022, as a joint meeting with the Canadian Society of Transplantation. To mark the 30th anniversary of the first Banff Classification, premeeting discussions were held on the past, present, and future of the Banff Classification. This report is a summary of the meeting highlights that were most important in terms of their effect on the Classification, including discussions around microvascular inflammation and biopsy-based transcript analysis for diagnosis...
March 2024: American Journal of Transplantation
https://read.qxmd.com/read/37977230/temporal-correlation-between-post-reperfusion-complement-deposition-and-severe-primary-graft-dysfunction-in-lung-allografts
#33
JOURNAL ARTICLE
Emily Cerier, Chitaru Kurihara, Taisuke Kaiho, Takahide Toyoda, Adwaiy Manerikar, Viswajit Kandula, Benjamin Thomae, Yuriko Yagi, Anjana Yeldandi, Samuel Kim, Diego Avella-Patino, John Pandolfino, Harris Perlaman, Benjamin Singer, G R Scott Budinger, Kalvin Lung, Borislav Alexiev, Ankit Bharat
Growing evidence implicates complement in the pathogenesis of primary graft dysfunction (PGD). We hypothesized that early complement activation post-reperfusion could predispose to severe PGD grade 3 (PGD-3) at 72 hours that is associated with worst post-transplant outcomes. Consecutive lung transplant patients (n=253) from January 2018 through June 2023 underwent timed open allograft biopsies at the end of cold ischemia (internal control) and 30 minutes post-reperfusion. PGD-3 at 72 hours occurred in 14% (35/253) of patients, 17% (44/253) revealed positive C4d staining on post-reperfusion allograft biopsy, and no biopsy related complications were encountered...
November 15, 2023: American Journal of Transplantation
https://read.qxmd.com/read/37945017/myeloperoxidase-staining-identifies-endothelial-injury-of-peritubular-capillaries-and-glomeruli-in-renal-antibody-mediated-rejection
#34
JOURNAL ARTICLE
Olabisi Afolayan-Oloye, Megan Moore, Dilip Samarapungavan, Yazan Al-Othman, Hassan D Kanaan, Steven Cohn, Wei Li, Sarah T Suliman, Krishna Putchakayala, Atul Singh, Gabriel Maine, Damanpreet S Bedi, Ping L Zhang
OBJECTIVE: It remains unclear if C4d staining is related to any peritubular and glomerular injury during antibody mediated rejection (ABMR). The goal of this study was to determine if myeloperoxidase (MPO) staining can highlight endothelial injury in peritubular capillaries (PTC) and glomeruli. METHODS: The study included 12 native negative controls, 19 transplant biopsies with borderline changes (BC) as transplant controls, and one group of renal transplant biopsies with ABMR as the study group (acute/chronic, n=22)...
September 2023: Annals of Clinical and Laboratory Science
https://read.qxmd.com/read/37940228/plasma-proteomics-to-identify-drug-targets-for-ischemic-heart-disease
#35
JOURNAL ARTICLE
Mohsen Mazidi, Neil Wright, Pang Yao, Christiana Kartsonaki, Iona Y Millwood, Hannah Fry, Saredo Said, Alfred Pozarickij, Pei Pei, Yiping Chen, Daniel Avery, Huaidong Du, Dan Valle Schmidt, Ling Yang, Jun Lv, Canqing Yu, Junshi Chen, Michael Hill, Michael V Holmes, Joanna M M Howson, Richard Peto, Rory Collins, Derrick A Bennett, Robin G Walters, Liming Li, Robert Clarke, Zhengming Chen
BACKGROUND: Integrated analyses of plasma proteomic and genetic markers in prospective studies can clarify the causal relevance of proteins and discover novel targets for ischemic heart disease (IHD) and other diseases. OBJECTIVES: The purpose of this study was to examine associations of proteomics and genetics data with IHD in population studies to discover novel preventive treatments. METHODS: We conducted a nested case-cohort study in the China Kadoorie Biobank (CKB) involving 1,971 incident IHD cases and 2,001 subcohort participants who were genotyped and free of prior cardiovascular disease...
November 14, 2023: Journal of the American College of Cardiology
https://read.qxmd.com/read/37895424/anti-cd20-antibody-and-calcineurin-inhibitor-combination-therapy-effectively-suppresses-antibody-mediated-rejection-in-murine-orthotopic-lung-transplantation
#36
JOURNAL ARTICLE
Hiroki Matsumoto, Hidemi Suzuki, Takahiro Yamanaka, Taisuke Kaiho, Atsushi Hata, Terunaga Inage, Takamasa Ito, Toshiko Kamata, Kazuhisa Tanaka, Yuichi Sakairi, Shinichiro Motohashi, Ichiro Yoshino
Antibody-mediated rejection (AMR) is a risk factor for chronic lung allograft dysfunction, which impedes long-term survival after lung transplantation. There are no reports evaluating the efficacy of the single use of anti-CD20 antibodies (aCD20s) in addition to calcineurin inhibitors in preventing AMR. Thus, this study aimed to evaluate the efficacy of aCD20 treatment in a murine orthotopic lung transplantation model. Murine left lung transplantation was performed using a major alloantigen strain mismatch model (BALBc (H-2d) → C57BL/6 (BL/6) (H-2b))...
October 11, 2023: Life
https://read.qxmd.com/read/37878180/nephrology-picture-c4d-positive-tubules-in-severe-bk-virus-nephropathy
#37
JOURNAL ARTICLE
Kanza Haq, Silvia Malvica, Avi Rosenberg, Sam Kant
No abstract text is available yet for this article.
October 25, 2023: Journal of Nephrology
https://read.qxmd.com/read/37855592/probiotic-enterococcus-faecalis-surface-delivering-key-domain-of-etmic3%C3%A2-proteins-immunoprotective-efficacies-against-eimeria-tenella-infection-in-chickens
#38
JOURNAL ARTICLE
Xinghui Pan, Rui Kong, Qiuju Liu, Zhipeng Jia, Bingrong Bai, Hang Chen, Wenjing Zhi, Biao Wang, Chunli Ma, Dexing Ma
Enterococcus faecalis MDXEF-1 strain was used as host bacteria to deliver surface-displayed key domains BC1 and C4D of the Eimeria tenella microneme 3 (EtMIC3) protein, BC1 fusion to dendritic cell (DC) targeting peptides (DCpep) (DC-BC1) and DC-C4D, respectively. The expression of target proteins in MDXEF-1/BC1-CWA, MDXEF-1/DC-BC1-CWA, MDXEF-1/C4D-CWA, and MDXEF-1/DC-C4D-CWA was verified. The systemic immune responses induced by oral immunization with recombinant E. faecalis were recorded. The immunized chickens were challenged with 4...
October 19, 2023: Microbiology Spectrum
https://read.qxmd.com/read/37853435/evidence-of-autoinflammation-as-a-principal-mechanism-of-myocardial-injury-in-sars-cov-2-pcr-positive-medical-examiner-cases
#39
JOURNAL ARTICLE
Margo E Hammond, Erik D Christensen, Michael Belenky, Gregory L Snow, Kevin Shah, M Elizabeth H Hammond
BACKGROUND: Disease from Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) remains the seventh leading cause of death in the United States. Many patients infected with this virus develop later cardiovascular complications including myocardial infarctions, stroke, arrhythmia, heart failure, and sudden cardiac death (20-28%). The purpose of this study is to understand the primary mechanism of myocardial injury in patients infected with SARS-CoV-2. METHODS: We investigated a consecutive cohort of 48 medical examiner cases who died with PCR-positive SARS-CoV-2 (COVpos) infection in 2020...
October 18, 2023: Diagnostic Pathology
https://read.qxmd.com/read/37806601/assessing-the-role-of-phosphorylated-s6-ribosomal-protein-in-the-pathological-diagnosis-of-pulmonary-antibody-mediated-rejection
#40
JOURNAL ARTICLE
Francesca Lunardi, Luca Vedovelli, Federica Pezzuto, Jerome Le Pavec, Peter Dorfmuller, Marina Ivanovic, Tahuanty Pena, Katharina Wassilew, Michael Perch, Sandrine Hirschi, Marie-Pierre Chenard, Rebecca A Sosa, Martin Goddard, Desley Neil, Angeles Montero-Fernandez, Alexandra Rice, Emanuele Cozzi, Federico Rea, Deborah J Levine, Antoine Roux, Gregory A Fishbein, Fiorella Calabrese
BACKGROUND: Pulmonary antibody-mediated rejection is still a challenging diagnosis as C4d has poor sensitivity. Previous studies have indicated that the phosphorylated S6 ribosomal protein, a component of the mammalian target of rapamycin (mTOR) pathway, is correlated with de novo donor-specific antibodies in lung transplantation. The objective of this study was to evaluate the phosphorylation of S6 ribosomal protein as a surrogate for AMR diagnosis in lung transplant patients. METHODS: This multicentre retrospective study analyzed transbronchial biopsies from 216 lung transplanted patients, 114 with antibody-mediated rejection and 102 without (19 with acute cellular rejection, 17 with ischemia/reperfusion injury, 18 with infection, and 48 without post-transplant complications)...
October 6, 2023: Journal of Heart and Lung Transplantation
keyword
keyword
11504
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.